University of Wollongong

Research Online
Illawarra Health and Medical Research Institute

Faculty of Science, Medicine and Health

2020

Endogenous doesn’t always mean innocuous: a scoping review of iron
toxicity by inhalation
Jody Morgan
University of Wollongong, jodym@uow.edu.au

Robin J. Bell
Alison L. Jones
University of Wollongong, alisonj@uow.edu.au

Follow this and additional works at: https://ro.uow.edu.au/ihmri
Part of the Medicine and Health Sciences Commons

Recommended Citation
Morgan, Jody; Bell, Robin J.; and Jones, Alison L., "Endogenous doesn’t always mean innocuous: a
scoping review of iron toxicity by inhalation" (2020). Illawarra Health and Medical Research Institute.
1525.
https://ro.uow.edu.au/ihmri/1525

Research Online is the open access institutional repository for the University of Wollongong. For further information
contact the UOW Library: research-pubs@uow.edu.au

Endogenous doesn’t always mean innocuous: a scoping review of iron toxicity by
inhalation
Abstract
Ambient air pollution is a leading risk factor for the global burden of disease. One possible pathway of
particulate matter (PM)-induced toxicity is through iron (Fe), the most abundant metal in the atmosphere.
The aim of the review was to consider the complexity of Fe-mediated toxicity following inhalation
exposure focusing on the chemical and surface reactivity of Fe as a transition metal and possible
pathways of toxicity via reactive oxygen species (ROS) generation as well as considerations of size,
morphology, and source of PM. A broad term search of 4 databases identified 2189 journal articles and
reports examining exposure to Fe via inhalation in the past 10 years. These were sequentially analyzed by
title, abstract and full-text to identify 87 articles publishing results on the toxicity of Fe-containing PM by
inhalation or instillation to the respiratory system. The remaining 87 papers were examined to summarize
research dealing with in vitro, in vivo and epidemiological studies involving PM containing Fe or iron oxide
following inhalation or instillation. The major findings from these investigations are summarized and
tabulated. Epidemiological studies showed that exposure to Fe oxide is correlated with an increased
incidence of cancer, cardiovascular diseases, and several respiratory diseases. Iron PM was found to
induce inflammatory effects in vitro and in vivo and to translocate to remote locations including the brain
following inhalation. A potential pathway for the PM-containing Fe-mediated toxicity by inhalation is via
the generation of ROS which leads to lipid peroxidation and DNA and protein oxidation. Our
recommendations include an expansion of epidemiological, in vivo and in vitro studies, integrating
research improvements outlined in this review, such as the method of particle preparation, cell line type,
and animal model, to enhance our understanding of the complex biological interactions of these particles.
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Abstract
BACKGROUND: Ambient air pollution is a leading risk factor for the global burden of disease. One
possible pathway of PM toxicity is through iron, the most abundant metal in the atmosphere.
OBJECTIVES: This paper will consider the complexity of iron toxicity by inhalation focusing on the
chemical and surface reactivity of iron as a transition metal and possible pathways of toxicity via
reactive oxygen species generation as well as considerations of size, morphology and source of PM.
METHODS: A broad term search of 4 databases identified 2189 journal articles and reports
examining iron by inhalation in the past ten years.
RESULTS: These were sequentially analysed by title, abstract and full-text to identify 87 articles
publishing results on the toxicity of iron containing particulate matter by inhalation or instillation to
the respiratory system. The remaining 87 papers were examined to summarise research dealing with
in vitro, in vivo and epidemiological studies involving iron PM or iron oxide by inhalation or
instillation. The major findings from these papers are summarized and tabulated.
DISCUSSION: Epidemiological studies have shown that exposure to iron oxide is correlated with
increased incidence of cancer, cardiovascular disease and several respiratory diseases. Iron PM has
been shown to induce inflammatory effects in vitro and in vivo and is able to translocate to remote
locations including the brain following inhalation. A likely pathway for the toxicity of iron containing
PM by inhalation is via the generation of reactive oxygen species which can lead to lipid peroxidation
and DNA and protein oxidation. Our recommendations include an expansion of epidemiological, in
vivo and in vitro studies, integrating research improvements outlined in this review, such as method
of particle preparation, cell line type, and animal model, to solidify our understanding of the
complex biological interactions of these particles.

Introduction
The World Health Organisation estimates that 4.2 million deaths occur every year as a result of
ambient air pollution exposure via chronic obstructive pulmonary disease, lung cancer, heart
disease, stroke or acute respiratory infections, with an additional 3.8 million deaths attributed to
exposure to household smoke and fuels (WHO 2018). Suspended PM is classified by aerodynamic
size in micrometres (μm) and measured by mass as milligrams per cubic metre. The terms PM10 and
PM2.5 generally describe airborne PM with an aerodynamic diameter of less than 10 μm or 2.5 μm
respectively (see Figure 1). Fine particles with an aerodynamic diameter of less than 2.5 μm exhibit
different properties to larger particles in terms of origin, composition, lung penetration, toxicity and
immunogenicity and different morphogenic characteristics in terms of surface area, surface
reactivity, and porosity (Achilleos et al. 2017; Chow and Watson 1998; Xing et al. 2016). Similarly,
ultrafine particles (PM0.1 <0.1 μm aerodynamic diameter) exhibit particular properties and
characteristics compared to coarse or fine particles. Ultra-fine particles (UFPs) are more likely to be
deposited in the alveolar region of the lung and are able to translocate through the epithelium
(Bräuner et al. 2007). Nanoparticles (NPs) are also classified as particles <0.1 µm in diameter

however these particles can be distinguished as NPs are deliberately synthesized for commercial use
whereas UFPs are by-products of combustion or other anthropogenic sources (see Figure 1).
Particulate air pollution has been specifically associated with adverse cardiovascular events including
myocardial infarction, hypertension, congestive heart failure, coronary heart disease and stroke
(Ebert et al. 2012; Laden et al. 2006; Stone et al. 2017). Both epidemiological and toxicological
studies into cardiovascular effects of coarse and fine PM are summarized in a recent review (An et
al. 2018). PM has been associated with an increase in emergency room visits and hospitalisations in
paediatric asthmatics (Pollitt et al. 2016) as well as a reduction in pulmonary function (S Wu et al.
2013). Ambient exposures to PM2.5 have also been associated with increases in lung cancer
mortality, where for each 10 µg/m3 increase in PM2.5 there was a 15-27% increase in lung cancer
mortality (Turner et al. 2011). Subsequently, the International Agency for Research on Cancer (IARC)
classified outdoor air pollution and PM as carcinogenic to humans (Group 1) in October 2013 (IARC
2013). Children, the elderly and the chronically ill appear to be particularly vulnerable to the adverse
effects of PM (Babadjouni et al. 2017; Cakmak et al. 2009; Valavanidis et al. 2008).
[Figure 1]
The toxicity of PM is complex due to a multitude of factors. The surface area of airborne particles
varies inversely with aerodynamic diameter (Oberdorster et al. 1996). Particle size also determines
deposition within the respiratory tract and the potential health impacts (Chow and Watson 1998).
The abundance and availability of surface reactive sites can also modulate reactivity with human
cells and tissues (Oberdorster et al. 1996). Variation in health outcomes from PM inhalation are
dependent not only on size and morphology but also on the type of components present in the PM
(Achilleos et al. 2017; Chen et al. 2013; Wu et al. 2011). Studies undertaken by Diociaiuti et al. (2001)
and Sandstrom and Forsberg (2008) support this proposition, reporting results more consistent with
variations in composition than size. Schwarze et al. (2006) suggest that current air-quality standards
based on the estimated mass of suspended particles may ignore the effect particle composition has
on toxicity. Notwithstanding the accepted use of size fractionated risk assessment of airborne PM,
the available literature suggests that physicochemical characterisation of particles is at least an
equally important predictor of toxicity and reactivity compared to size.
Iron is the most abundant metal in the atmosphere (Ault et al. 2012; Beck-Speier et al. 2009).
Atmospheric iron comes from a variety of sources: brakes and abrasion of train rails (Moreno et al.
2017; Wang et al. 2016); vehicle exhaust as iron scraps from piston motion (Li et al. 2017; Liati et al.
2013); coal and oil fly ash (Lu et al. 2009; Silva et al. 2009); mining activities such as drilling, blasting,
collection and transportation (Tavares et al. 2014); fumes associated with welding (Falcone et al.
2018b); steel production particularly the formation of EAF-dust from electric arc furnace recycling of
scrap iron (Wu et al. 2014); waste incineration (Yu et al. 2013); and naturally occurring geogenic
dusts (DeWitt et al. 2017; Pritchard et al. 1996).
Concentrations of iron in the atmosphere vary significantly, largely due to particle source. For
example in air pollution in Switzerland the iron concentration ranged from 0.07 – 1.4 µg/m3
(Bukowiecki et al. 2005), however, much higher concentrations have been identified in mineral dusts
in the Middle East, 0.42 – 2.85 µg/m3 (Engelbrecht et al. 2009) and in subway stations, 2.67 – 47.88
µg/m3 (Wang et al. 2016). Source also has an impact on chemical composition. Iron-rich particles in

the atmosphere are commonly found to be additionally associated with other elements including
other transition metals, aluminium, silica, potassium, sulfur and other organic particles (Ault et al.
2012, Li et al. 2017, Sanderson et al. 2016, Tavares et al. 2014). Li et al. (2017) analysed the PM in
Shanghai, China in late 2016 and found iron present in both the coarse (>1 µm) and fine (<1 µm)
fractions. This iron was commonly associated with the presence of oxygen, often in the form of
hematite (α-Fe2O3) and magnetite (Fe3O4) oxides. In all cases it is important to consider that the iron
containing PM is often associated with additional components which increases the complexity of any
potential toxicity.
Iron has long been considered one of the more biologically innocuous heavy metals, in part due to
its high concentration in the human body and its central role in human physiology. As such, it is has
often been ignored in studies examining the toxicology of PM. However, transition metal content
and iron mobilization have both been associated with the adverse health effects of PM (Wu et al.
2018). Poorly-liganded iron has been implicated in a number of neurological diseases including
Parkinson’s, Huntington’s, and Alzheimer’s diseases (Kell 2010). Genetic hemochromatosis patients,
who have an overload of iron, suffer complications involving hepatic failure from cirrhosis or
hepatocellular carcinoma with rates 93-240 times that of age-matched controls (Toyokuni 2002,
2009). A possible pathway to injury is the production of reactive oxygen species when transition
metals, such as iron, are present, which leads to inflammation and subsequent injury (Funke et al.
2013; S Wu et al. 2013). Due to the inherent risks associated with this humans have extensive
pathways for dealing with free iron (Dev and Babitt 2017) however, when these pathways are
overwhelmed via excessive exposure or genetic variability between individuals, this may lead to
injury or illness.
This paper will consider the complexity of iron toxicity by inhalation exposure focusing on the
chemical and surface reactivity of iron as a transition metal, possible pathways of toxicity via
reactive oxygen species, considerations of size and morphology, and health outcomes associated
with iron from different sources, including occupational sources. Conclusions drawn from
epidemiological, in vivo and in vitro studies from the past 10 years will be summarized, with the
latest research on nanomaterials used to inform toxicity data on UFPs.

Methods
A detailed search of available literature from the past 10 years on iron oxide containing PM was
conducted on 03 April 2019. The databases employed were ProQuest, Scopus, Web of Science and
PubMed. The literature search was left deliberately broad to ensure all results were captured. Three
separate searches were used. The search strategy employed for all databases was as follows:
1. particulate matter AND iron oxide AND (2009/01/01 to present)
2. ‘iron oxide’ AND (inhalation OR inhale) AND (2009/01/01 to present)
3. iron AND (in vivo OR in vitro OR epidemiolog*) AND (inhalation OR inhale OR instillation OR
instill) AND (2009/01/01 to present)
Results were limited to reports and journal articles written in English.

Results
Results from the three searches outlined above were pooled. This database search identified 2189
papers, with an additional 23 papers located from other sources. Once duplicates were removed this
left 1276 results (Figure 2). These articles were screened by title and 678 records which were
irrelevant to the topic or were dealing with non-atmospheric forms of iron containing PM were
removed. A further 467 were removed following a screening of abstracts using the same exclusion
criteria outlined above. The full-text of the remaining 131 were reviewed and 44 additional papers
were removed. Only papers describing raw data dealing with in vivo, in vitro or epidemiological data
following instillation/inhalation of iron containing PM were included. Reviews were removed.
General PM papers were only included if they provided specific data on the iron component. The
remaining 87 papers were included in the review. These articles are marked in the reference list with
an * and the major findings from each paper are summarized in Tables SM1 – SM5 in the
Supplementary Material.
[Figure 2]

Discussion
Uptake and fate of PM following inhalation
The first hurdle when considering toxicity by inhalation is determining the biological fate of PM
following entry into the respiratory system. The region of the respiratory system where PM is most
likely to deposit is largely dependent on breathing pattern (Brown et al. 2008) and particle size, with
coarse particles (PM10) more likely to deposit in the upper nasopharygeal region and UFPs (PM0.1)
more likely to deposit in the lower pulmonary region (see Figure 3) (Chow and Watson 1998).
[Figure 3]
The second consideration is twofold. Firstly, once in the lung, are the particles incorporated into cells
and are they able to induce a biological response that will lead to significant adverse health, such as
severe inflammation? And secondly, are the particles able to translocate from the lung into the
blood stream and potentially to other organs to cause secondary effects?
Mechanisms of incorporation from the lung into the body include dissolution, translocation into
epithelial cells and interstitial tissue, migration of particles caused by mucociliary motion, and
migration caused by incorporation into alveolar macrophages (see Figure 4). Non-biosoluble
particles deposited in the lungs are cleared by mucociliary transport moving particles from the nasal
passage and trachea-bronchiolar region to the oropharynx, where they are swallowed (ECETOC
2013) or recognized by alveolar macrophages (AM) and engulfed (Kunzmann et al. 2011). Studies
involving titanium oxide (TiO2) particles have shown that following inhalational deposition deep in
the rat lung, particles were able to translocate to the tracheobronchial and mediastinal lymph nodes
(Morfeld et al. 2012, Warheit et al. 1997). However, this has not been analysed for iron oxide
containing particles and the single study investigating carbonyl iron, found translocation to the

tracheobronchial lymph nodes only in cases of inhalation of extremely high concentrations (250
mg/m3) (Warheit et al. 1997).
In vitro studies involving iron NPs have been shown to be incorporated into a variety of cell types,
likely via phagocytosis or pinocytosis, leading to the formation of NP containing membrane-bound
vesicles (see Figure 4) (Guo et al. 2009; Könczöl et al. 2011; Lee et al. 2014; Liu et al. 2012; Zhu et al.
2011). Following incorporation of these particles, physical changes to the cell that have been
observed include: mitochondrial swelling and disappearance of the mitochondria (Zhu et al. 2011) as
well as the disappearance of other organelles (Park et al. 2014a); changes in cellular morphology
(Dwivedi et al. 2014); and separation of cells producing intercellular gaps (Apopa et al. 2009).
Changes to cytosolic organelles and increased gene transcription suggest that cell death in some cell
lines may be driven by autophagy via oxidative pathway, ferroptosis, and not apoptosis (Park et al.
2014b).
Following cellular uptake, iron oxide NPs are found in endosomes or lysosomes. Once inside
lysosomes, enzymes act to decompose these particles releasing iron into the total labile iron pool
(Liu et al. 2013). Additionally, the acidic pH (4.5-5.0) inside the lysosome can lead to increased
solubilisation of iron and potential chemical conversion of iron oxide into a more redox active form
(see Figure 4) (Guo et al. 2009).
Under normal physiological conditions levels of unliganded iron are very low. Iron in both ferrous
and ferric forms is highly reactive and kept bound to proteins or chelated to avoid generation of
reactive oxygen species (ROS) (see Chemistry of Iron section). However, unlike the digestive system,
the lung does not have specific pathways for receiving large quantities of iron, with a focus on
sequestering the metal into a less reactive state mostly through storage in ferritin (Ghio et al. 2009).
Alveolar macrophages (AMs) are important mediators of iron homeostasis by controlling cellular iron
import and storage, with AMs being a major pathway for iron clearance from the lung (Allden et al.
2019, Philippot et al. 2014). In line with this, expression of membrane bound proteins such as CD71,
which is responsible for the uptake of iron-bound complex diferric transferrin, appear altered in
patients with progressive fibrotic lung disease (Allden et al. 2019). While critical to a complete
understanding of iron within the body, homeostasis and control of iron stores are outside the scope
of this review. For additional information see recent reviews by Ganz and Nemeth (2015) and
Sukhbaatar and Weichhart (2018).
An in vivo study in man examined the response to iron particles where an instilled dose of
synthesized Fe2O3 induced a transient acute inflammatory response (Lay et al. 1999). The dose used
in this study was equivalent to breathing heavily polluted urban air for 24 to 48 hours. The authors
selected this particle due to its low reactivity and were surprised by the extent of the inflammatory
response. Subsequent studies have identified significant increases in bronchoalveolar lavage fluid
(BALF) cells, particularly neutrophils and alveolar macrophages across a range of human, mouse and
rat models (see Table SM3 and Table SM4 in the Supplementary Material) (Beck-Speier et al. 2009;
Park et al. 2015; Srinivas et al. 2012; Sutunkova et al. 2016). An up to 20-fold increase in cytokines
associated with inflammatory response has been observed following both inhalation and instillation
of iron particles in vivo (Park et al. 2010; Park et al. 2015; Srinivas et al. 2012), particularly IL-12, IgM
and IgG as well as IL-6, IL-4 and IL-5. Additionally, Park et al. (2010) found a significant increase in IgE
in blood but not BALF which is important as most studies focus on BALF analysis.

[Figure 4]
In addition to their ability to induce transient acute inflammation, UFPs are also able to translocate
outside the lung with clearance and retention controlled by interstitilization rather than macrophage
mediated clearance, with rapid translocation to endothelial and interstitial sites, then onto
lymphatic channels and the blood (ECETOC 2013). Iron particles instilled in rats have been shown to
pass through the alveolar-capillary barrier and into the systemic circulation less than 10 minutes
after instillation and have an extremely long elimination half-life (22.8 days) (Zhu et al. 2009). NPs
have been located (via TEM) in the olfactory region of the brain of rats following inhalation
suggesting possible translocation from the nasal cavity along the olfactory nerve fibres (see Figure 4)
(Hopkins et al. 2018; Sutunkova et al. 2016). Near edge X-ray absorption fine structure (XANES)
measurements have also determined that Fe3+ levels were significantly increased in the olfactory
bulb and brain stem following instillation in mice (Wang et al. 2011) as well as the cortex,
hippocampus and midbrain (Wang et al. 2011; J Wu et al. 2013). Instilled and inhaled iron has also
been found in organs rich in mononuclear phagocytes including the liver, spleen, kidney and testicles
(Zhu et al. 2009).
A large number of studies determining inhalational toxicity use instillation as a dose delivery
method. This is problematic as: instillation bypasses the upper respiratory tract and is unlikely to
reach the lower alveolar regions; it results in high exposure concentrations which are physically
isolated leading to uneven exposure; these high concentrations are likely to overwhelm clearance
mechanisms in sensitive models; and particles suspended in solution are unlikely to have surface
chemistry and agglomeration properties similar to those in the aerosol (ECETOC 2013). Therefore
care needs to be taken when considering these results, particularly in cases where comparative
inhalational studies are not available.
It is important to note that rats and mice have been used for the vast majority of in vivo PM studies,
however, there is a different distribution of inhaled particles in the rat and the human lung (ECETOC
2013) due to variances based on function, with rodents being nose-only breathers and humans
breathing through both nose and mouth, as well as structural variations (Brown et al. 2008).
Additionally, significant differences have been found between the particle clearance rates in small
mammalian models (mice and rats) and larger models (canines and humans) with much slower
clearance seen in the larger species (Kreyling et al. 2006) (implications of lung overload in rats are
discussed in detail in the Challenges of Research section below). Long term clearance of particles
from the alveolar region of the lung varies significantly with rats having a retention half-time of 6080 days but up to two years in humans (Brown et al. 2008).
Chemistry of Iron
Iron present as a component of PM is usually in the Fe2+ or Fe3+ form, often as oxides (FeO, Fe2O3 or
Fe3O4), particularly when obtained from combustion or mineral sources. While pure iron and other
iron salts, including carbonate, sulfate and chloride, may be in PM they are usually present in much
lower concentrations. It should be noted that in PM these iron oxides are not usually in isolation but
are associated with other oxides, metals and carbon (Engelbrecht et al. 2009, Li et al. 2017, Tavares
et al. 2017).

As a highly reactive transition metal iron can initiate Fenton-like reactions (equation 2 Figure 5)
which generate reactive oxygen species (ROS) which can, in turn, promote localized adverse health
effects (Beck-Speier et al. 2009). The hydroxyl radical, which is produced via this reaction, is
extremely reactive, with a half-life of about one nanosecond (Kehrer 2000). Pathways of ROS
damage via the hydroxyl radical include DNA oxidation and subsequent damage of both bases and
the deoxyribose backbone leading to the potential for increases in cancer; lipid peroxidation, which
involves the reaction of free radicals with the fatty acids in the cell membrane, leading to membrane
disruption and potentially ferroptosis; and protein damage via protein oxidation (Kehrer 2000; Valko
et al. 2007) (see Figure 5).
[Figure 5]
The majority of papers showing iron particle induced cytotoxicity suggest that iron controlled
generation of ROS is the major pathway of toxicity with a significant increase in ROS seen in
numerous in vitro studies (Bhattacharya et al. 2012; Könczöl et al. 2011; Park et al. 2014a; Park et al.
2014b; Rajiv et al. 2016; Zhu et al. 2011). Increase in ROS production has also been shown following
in vivo exposure to Fe3O4 (Dwivedi et al. 2014; Könczöl et al. 2013; J Wu et al. 2013) and Fe2O3 (Zhu
et al. 2011). Interestingly, some papers which failed to show a significant increase in ROS when
exposed to iron particles alone, did show a significant increase in ROS when exposed to iron particles
in the presence of a co-oxidant such as hydrogen peroxide (Guichard et al. 2012), carbon black (Berg
et al. 2010; Guo et al. 2009), ascorbic acid (Bhattacharya et al. 2009) or quinones (Lyngsie et al.
2018; Valavanidis et al. 2008) suggesting that redox cycling might play an important part in this
process.
Further evidence of the potential for a redox cycling pathway of toxicity can be seen in in vitro
studies showing evidence of cellular incorporation of both carbon black and iron oxide with colocalisation in endosomal-like or lysosomal-like structures (Berg et al. 2010). Carbon black can
reduce Fe3+ to Fe2+ which is membrane permeable and can undergo further intracellular redox
reactions in the cytosol leading to the generation of ROS (Berg et al. 2010). Carbon black and Fe2O3
co-incubated with H2SO4, to replicate lysosomal conditions, produced both Fe2+ and Fe3+ suggesting
redox cycling in lysosomes is possible (Guo et al. 2009). Supporting this there was an increase in
generation of ROS in vitro following exposure to Fe2O3 in the presence of carbon black. Interestingly,
this increase was not concentration dependent for either particle, suggesting that the ratio between
the iron oxide and the carbon black may be of importance (Berg et al. 2010; Guo et al. 2009). Low
levels of cytotoxicity were seen in this study, which could be reduced by surface oxidising the carbon
black, suggesting that the redox cycling between these particles was responsible for the toxicity
(Berg et al. 2010). Significant protein oxidation was seen for Fe2O3 in the presence of carbon black as
well as lipid peroxidation when both particles were in combination but not for either particle alone
(Guo et al. 2009). This effect was also seen with iron oxide in the presence of soot particles which
caused a significant increase in oxidized glutathione, indicative of oxidative stress (Zhong et al.
2010).
In humans there are several factors opposing the iron-induced ROS damage pathway, including the
low biosolubility of iron and the sequestering of free iron by binding proteins (Beck-Speier et al.
2009). Under normal biological conditions iron is stored as an iron-ferritin complex, however, under
pathological conditions associated with the production of ROS, e.g. cancer and atherosclerosis, iron

can be released. Free iron can be reduced to Fe2+ and then participate in the Fenton reaction to
produce the hydroxyl radical (Singh et al. 2010). An in vitro study showed that iron oxide NPs (Fe2O3)
caused an increase in endothelial cell permeability, mediated via ROS-modulated microtubule
remodelling leading to the formation of intercellular gaps (Apopa et al. 2009). This permeability
increased within 10 minutes of exposure to NPs and persisted for up to 5 hours after exposure
ceased (Apopa et al. 2009).
Formation of ROS requires the aerosol fraction of iron to be soluble (Longo et al. 2016), thus we
need to determine if iron can become bioavailable following inhalation. This is related both to the
deposition and translocation described earlier as well as the solubility of the iron within the PM. Iron
solubility has significant variability relating to iron source (Pritchard et al. 1996). Fu et al. (2012)
analysed the total soluble fraction of iron from a range of sources and found that under low pH
conditions in the presence of light, mineral dust had a total iron content of 3.1%, 4.5% of which was
soluble iron, whereas fly ash from an oil burning plant contained 9.3% iron, 85.9% of which was
soluble. There were also significant differences when comparing industry to natural dusts with iron
sourced from industry-derived PM being ~4% soluble compared with mineral PM ~0.4% soluble (Ault
et al. 2012; Fu et al. 2012). It has been noted that in mineral dusts the solubility of iron is inversely
proportional to the total iron content (Longo et al. 2016). Interestingly, the type of soluble iron
present also varied by source with iron from biomass burning present mainly as ferrous iron (Fe2+)
where total dissolved iron from fly ash and mineral dust was present mostly as ferric iron (Fe3+) (Fu
et al. 2012).
Additionally, solubility of iron in the aerosol has been shown to increase with estimated travel time
from the source, which is likely linked to an associated decrease in pH with travel time (Longo et al.
2016). Despite the fact that Fe2+ is more soluble than Fe3+ no correlation was seen between
oxidation state and solubility in a study by Longo et al. (2016). Solubility also varied by concentration
with lower concentrations producing more soluble iron (by %) resulting in no clear concentrationdependent toxicity (Zhu et al. 2011). Additionally, Fe2O3 particles showed moderate solubility in
alveolar macrophages despite being insoluble in extracellular media suggesting composition of the
media used to deliver the particles can alter solubility and therefore also potentially toxicity (BeckSpeier et al. 2009). The temperature at which the iron oxide particles are created can also have a
marked effect on the solubility of the iron, particles created at a lower temperature (250oC) have
been shown to have a water-soluble iron content 23 fold higher than those produced at a higher
temperature (800oC) (Lay et al. 2001). The fact that PM solubility could be controlled by particle size,
morphology, composition, oxidation state of iron, or particle ageing processes in aerosols such as
photoreduction or organic ligand association (Longo et al. 2016) or a combination of these factors,
exacerbates the complications seen with aerosol iron chemistry.
Following phagocytosis particles can be dissolved in lysosomes, due to a lower pH, generating free
iron ions which can subsequently be involved in generating ROS (Zhu et al. 2011). Solubility of both
Fe2+ and Fe3+ has been shown to increase with increasing acid strength and epithelial cells exposed
to Fe3O4 particles saw a decrease in cell viability and an increase in interleukin production when acid
or secondary organic aerosol or both were added along with the particles (Baber et al. 2011; Ghio et
al. 2009). We know that iron becomes bioavailable following inhalation as studies have shown a
significant increase in ferritin expression following inhalation in rats indicating an increase in

bioavailable iron (Zhong et al. 2010; Zhou et al. 2003).
Biological Effects of Iron
Cytotoxicity and Genotoxicity
Cytotoxicity of iron NPs varies greatly between studies and care needs to be taken when drawing
conclusions from single studies as different cell lines, particle exposure time, types of particles and
even method of preparation of particles show significant variation in their induced level of
cytotoxicity (see Table SM1 of Supplementary Material for a summary of iron oxide particle in vitro
studies). Fe2O3 NPs caused a significant decrease in metabolic activity (MTT assay) from 3.75 µg/ml
in MSTO cells but tolerated 30 µg/ml in the slower proliferating 3T3 cells in the same study
suggesting significant variation in cell types used in in vitro studies (Brunner et al. 2006). Some
studies have concluded that iron particles produced no cytotoxic effects or were cytotoxic only at
extremely high concentrations (Freyria et al. 2012; Szalay et al. 2012; Williams and Zosky 2019);
where other studies have shown moderate decreases in cell viability (20-30% at 50-200 µg/ml)
(Könczöl et al. 2011; Rajiv et al. 2016); and further studies have shown substantial decreases in cell
viability (70-90% at 50-100 µg/ml) (Dwivedi et al. 2014; Park et al. 2014a; Zhu et al. 2011).
Overall no clear conclusions can be drawn from these studies due to the significant variation
between methods although it can be seen that monkey kidney cell lines seem to show lower
cytotoxicity than human epithelial cell lines or alveolar macrophages. Additionally, flame synthesized
particles appear to produce a higher cytotoxicity than purchased NPs, suggesting that surface
oxidation or morphology may be important. Direct examination of freshly prepared flame
synthesized, chemically synthesized and purchased NPs would be a useful future study to allow for
direct comparison of these particles.
Genotoxic effects have also shown significant variation between studies. Iron particles have been
shown to produce significant DNA damage (p ≤ 0.001) at concentrations as low as 10 µg/cm2
(Bhattacharya et al. 2009). With Fe3O4 NPs showing significant oxidative DNA damage compared to
control (Karlsson et al. 2009; Totsuka et al. 2014) and Fe3O4 NPs and bulk particles producing
genotoxic effects (via DNA migration) in epithelial cells that were partially inhibited by ROS
scavengers (Könczöl et al. 2011).
Pulmonary Effects
A significant increase in lactate dehydrogenase (LDH) was seen in a number of studies indicating
cellular injury (Demokritou et al. 2010; Park et al. 2015; Zhong et al. 2010) as well as an increase in
total protein indicating altered vascular permeability (Srinivas et al. 2012). A 2.0 mg/kg dose of iron
oxide NPs in mice showed a six fold increase in apoptotic cells (Park et al. 2010; Park et al. 2015)
with increasing intracellular iron concentrations shown to promote ferroptosis, a nonapoptotic form
of cell death characterized by reduced mitochondrial size with increased membrane density which is
believed to occur via the iron-mediated accumulation of lipid peroxidation (Manz et al. 2016).
Alveolar wall thickening indicating potential fibrosis (Zhu et al. 2008) and dose dependent weak
pulmonary fibrosis and interstitial inflammation (Szalay et al. 2012) are just some of the structural
changes observed in in vivo models following instillation of iron particles. Mice exposed to long term

Fe3O4 NPs showed a significant increase in alveolar wall thickness, peribronchiolar wall thickness,
perivascular wall thickness and interstitial lung inflammation (Presume et al. 2016; Teeguarden et al.
2014). Additionally, following iron particle instillation, rats decreased their total body weight with
significant decrease in lung weight (Szalay et al. 2012).
Increased iron levels have also been correlated with several types of cancer with cellular redox
imbalance found in various cancer cells (Valko et al. 2007). Iron dysregulation has been associated
with mutagenesis and enhanced tumour growth (Manz et al. 2016). Long term exposure (10 weeks)
to low dose nano Fe2O3 resulted in neoplastic-like transformation of human small airway epithelial
cells likely via an ROS pathway involving altered iron homeostasis (Stueckle et al. 2017).
Iron dysregulation is also a feature of chronic obstructive pulmonary disease (COPD) (Cloonan et al.
2017) with serum iron and ferritin increased in smoking patients with COPD compared with healthy
non-smokers. There were also significant increases seen for both iron and ferritin in lavage fluid
(Ghio et al. 2008) with increased rates of COPD among ferrous metallurgy workers which maintained
significance when adjusting for age and smoking status (Bala and Tabaku 2010). Figure 6 shows a
side-by-side comparison of the locations of steel processing plants (Figure 6a) and iron ore mining
locations (Figure 6c) in the UK compared with relative risk of COPD mortality by local authority
district 2008-2012 (Figure 6b). As can be seen from this graphic there is a high correlation between
areas with significant iron ore mining and processing and the risk of COPD. It should be noted that it
is likely that areas with increased iron ore mining and processing also have increased general
industrial activity unrelated to iron. A recent review by (Cloonan et al. 2017) suggested that
exposure to iron containing particles in association with genetic suggestibility through modification
of IREB2 may be contributors to COPD. IREB2 is an iron regulatory protein involved in the
maintenance of cellular iron metabolism. IREB2 protein expression is higher in the lung tissue
samples of people with COPD. This with the addition of evidence of iron imbalance in cases of
pulmonary inflammation suggests that IREB2 may play a role in the pathogenesis of COPD (DeMeo
et al. 2009).
[Figure 6]
Cardiovascular Effects
There are three broad hypotheses about how exposure to PM causes cardiovascular disease:
(1) Deposition of particles in the lung provokes a low-grade alveolar inflammation with a
secondary systemic inflammatory response resulting in downstream cardiovascular
exacerbations in susceptible individuals with the release of prothrombotic and inflammatory
cytokines into the circulation (Sun et al. 2010; Valko et al. 2007; Wu et al. 2016a; Zhu et al.
2011).
(2) Central nervous system manipulation of cardiovascular function following PM exposure via
alterations in autonomic nervous system activity which can directly and indirectly alter
cardiac function (Stone et al. 2017).
(3) UFPs translocating into the circulation adversely affecting the heart by initiating arrhythmias
and sudden death in susceptible subjects or having a direct effect on atherosclerotic plaques
in vasculature (Sun et al. 2010; Tarantini et al. 2013).

Transition metals, including iron, in dust/soil have shown significant positive correlation with
endothelin-1, intercellular adhesion molecule 1 and Ox-LDL which are biomarkers of endothelial
function (Wu et al. 2015; Wu et al. 2016a). Increased levels of these biomarkers have been
associated with an elevated risk of atherosclerosis and cardiovascular disease. When serum ferritin
levels are high under inflammatory conditions there are also hypercoagulability and fibrin changes
(Pretorius and Kell 2014). Additionally, the morphology of red blood cells alters in patients with
haemochromotosis and when excess unliganded iron is added which can be reversed by the addition
of iron chelators (Pretorius et al. 2014; Pretorius and Kell 2014).
Effect of Particle Size
Course particles (PM10), those with an aerodynamic diameter of 2.5 - 10 µm, generally derive from
resuspensions of dust and soil as well as sea salts, pollens, spores and crustal material from roads,
farming and mining (Pope and Dockery 2006). Coarse particles are more likely to be deposited in the
bronchial airways, affecting respiratory pathophysiological changes consistent with asthma, COPD
and pneumonia (Sandstrom and Forsberg 2008). Fine particles (PM2.5), those with an aerodynamic
diameter of 0.1 - 2.5 µm, primarily derive from combustion processes including diesel and petrol,
coal burning, wood burning and industrial processes such as steel mills, paper mills and smelting
operations (Pope and Dockery 2006) and are more likely to be deposited in the small airways and
alveoli, leading to cardiovascular events and alveolar-capillary membrane dysfunction (Sandstrom
and Forsberg 2008). UFPs, those with an aerodynamic diameter of <0.1 µm, are commonly created
from industrial and urban environments. UFPs commonly merge to form agglomerates of particles
more than 100 nm across. In addition to the altered deposition profile of larger particles,
agglomerates may exhibit a range of discrete and/or synergistic toxicities related to individual
chemical constituents. The high agglomeration of UFPs is due to an increase in van der Waals forces
and has been shown to vary by media and pH (Bhattacharya et al. 2012). Iron containing particles
have been identified in all size components with concentrations and chemical make-up dependent
on source (Genga et al. 2018, Yadav et al. 2019, Yang et al. 2019).
The smaller component of iron containing PM10 is able to incorporate into membrane bound
vesicles, however, the larger component does not. In contrast, NPs have been shown to be
incorporated into epithelial cells in aggregates of up to hundreds of particles (Könczöl et al. 2011).
Many papers still consider NPs and ambient UFPs separately despite their obvious toxicological
cross-over. Stone et al. (2017) published a detailed literature review comparing toxicological studies
involving man-made and ambient particles with a diameter <100 nm and found that UFPs and NPs
appear to share common toxicological mechanisms, in particular oxidative stress and inflammation.
A major variation is that iron containing NPs are often coated which will significantly alter toxicity
profiles for these species with changes in surface charge, agglomeration, cellular location and
membrane solubility (Liu et al. 2013).
Nano sized iron oxide particles induce an inflammatory response with significantly increased number
of BALF neutrophils in rats exposed to nano Fe2O3 particles (Ban et al. 2012; Demokritou et al. 2010;
Park et al. 2015; Srinivas et al. 2012; Sutunkova et al. 2016). Additionally, some studies have shown
an increase in ROS (Guichard et al. 2012) and cytotoxicity (Bhattacharya et al. 2012) for NPs over
micro particles, however, other studies have shown no difference between them (Karlsson et al.
2009).

Effect of Morphology
Particles generated for in vitro research by various methods vary in size, surface area and
morphology from other generated particles and naturally occurring particles in particular. Fly ash
particles (Figure 7a), are relatively uniform in spherical shape and size, which is a feature of all iron
oxide particles produced by combustion methods. The spherical shape is due to the molten nature of
materials at high temperatures (Li et al. 2017). However, these particles react with other chemicals
in the atmosphere causing them to lose sphericity as they move away from the source (Ault et al.
2012). In contrast, mineral dusts and salts (Figure 7b) are irregular in shape.
[Figure 7]
Particles formed by physically abrasive methods including grinding and crushing processes generally
produce particles with rough and splintery morphologies. A good example of this are the iron
containing particles found in subway PM (Figure 8) (Moreno et al. 2015). These particles are formed
by the abrasion of train brakes on railway tracks resulting in sharp, elongated particles with a rough
flake-like surface which are likely to produce significantly different toxicological effects compared to
the spherules produced by combustion processes.
[Figure 8]
Iron oxides in different oxidation states also have varied morphologies. Comparative studies
determined that needle-like γ-Fe2O3 showed a higher level of toxicity compared to the equivalent
spherical Fe3O4 NPs (Figure 9) (Park et al. 2015). Similarly, rod-shaped particles were significantly
more cytotoxic than spherical nano or micro Fe2O3 particles in rat macrophage cells (Lee et al. 2014).
Nanoparticles with elongated shape, such as needle or rod-shaped particles, have altered
recognition by alveolar macrophages which can lead to accumulation (Braakhuis et al. 2014, Kuroda
et al. 2018). Rigid, elongated fibres may also be physically trapped more readily in the lung than their
spherical counterparts (Kuroda et al. 2018).
[Figure 9]
Effect of Source
Exposure to iron oxides occurs in a variety of occupations, including welding, foundry work, metal
forming and manufacturing, as well as iron-ore mining and transport. Generally, workers are
exposed to substantially larger doses of airborne pollutants than the general population when at
work. Below, we consider PM from a range of sources known to contain high concentrations of iron.
Steel Production and Foundries
Electric arc furnaces, which are one method used to recycle iron into steel, produce between 10 and
25 kg of dust per ton of steel (Bakkar 2014). This dust contains high quantities of iron, but is
contaminated with other metals including lead, chromium, cadmium and zinc (Bakkar 2014). There
was a significant increase in malignant tumours of the larynx, trachea, bronchi and lungs for electricarc furnace workers (SMR=3.35) with the highest rates attributed to those exposed for 1-5 years
(SMR=4.35) (Cappelletti et al. 2016). Squamous metaplasia (benign changes to cells) and cytological
atypia (atypical cells which may develop into cancerous tissue) were both significantly higher in iron

industry workers than controls (Ahmed et al. 2013). Morbidity analysis also found a significant
increase in relative risk for diabetes (RR=2.24), rheumatoid arthritis (RR=6.18), non-complicated
hypertension (RR=2.23) and complicated hypertension (RR=2.01) among electric-arc furnace workers
(Cappelletti et al. 2016).
There are high rates of COPD among steel-workers with a calculated relative risk of developing COPD
of 5.51, which when adjusted for age and smoking became 5.11 (Bala and Tabaku 2010). Iron oxide
was also highly associated (OR = 9.61) with obstructive pulmonary function impairment (Ryu et al.
2013). Iron industry employees also had significantly higher rates of viral infection and yeast
infection (moniliasis) compared to controls (Ahmed et al. 2013). Oxidative markers in exhaled breath
condensate were elevated in workers exposed to iron oxide pigments compared to controls
(Pelclova et al. 2016). Additionally, iron was associated with endogenous thrombin production, as a
marker for global coagulation, having the highest regression coefficient for any of the metals
analysed in this study (53.6 95% CI -16.5 to 123.7), however, this was not significant due to a large
confidence interval (CI) (Tarantini et al. 2013). A separate study found a significant increase in MDA
and 8-OH-dG, both of which are markers of oxidative stress, and tail moment which is a marker of
DNA breakage, in exposed foundry workers (Liu et al. 2009). Both of these studies failed to focus on
iron, concentrating instead on other metals despite the fact iron was the metal of highest
concentration in the PM.
Fly Ash
Coal burning is a major source of iron-containing fly ash. Magnetic phases of fly ash are particularly
high in iron which has been shown to be present in a wide variety of mineral phases including
magnetite, hematite, maghemite, iron-silicates, ferrite spinel complexes and others (Bourliva et al.
2017). Inhalation of fly-ash particles has been associated with respiratory and cardiovascular disease
(Bourliva et al. 2017).
Subway Particles
Most inhalable-sized iron containing PM on subway platforms are flakes composed of iron oxide NPs
usually also associated with additional nanomaterial products from the parent material of brake and
rail systems (Moreno et al. 2015) with a coating of salts or small particles of mineral matter such as
carbonates, clay and quartz (Moreno et al. 2017). There is a large amount of variation between
subway systems due to design, component and usage differences (Wang et al. 2016). In subway
stations where the train tracks were separated from the station area by a solid wall with sliding
doors there is a significant decrease in the ambient PM2.5 (Moreno et al. 2015; Wang et al. 2016)
providing a useful mechanism by which to decrease exposure.
Exposure to subway particles caused concentration dependent cytotoxicity in CHO-1 cells at
concentrations ≥ 25 µg/ml but not BEAS-2B cells (Jung et al. 2012) and a 4-fold increase in
intracellular ROS (Karlsson et al. 2008). Comet assay on CHO-K1 cells showed an increase in DNA
breakage at all concentrations ≥ 1.6 µg/ml (Jung et al. 2012). Micronuclei frequency, an indicator of
chromosomal damage, increased significantly and was inhibited by ROS scavengers (Jung et al.
2012). DNA damage caused by subway particles was almost 2 fold higher than either Fe2O3 or Fe3O4
particles alone, with an increased ability to cause oxidative stress (Karlsson et al. 2008) suggesting

morphological, surface reactivity or synergistic factors are likely involved. Exposure of human
primary bronchial epithelial cells to subway PM showed an increase in IL-8 release and a
concentration dependent increase in ROS which decreased with addition of either an iron chelator
(desferrioxamine) or free radical scavenger (N-acetylcysteine) (Loxham et al. 2015). In a study
investigating the genotoxicity of PM from various sources including wood combustion, tyre wear and
street PM, subway particles were the most genotoxic tested with 4-5 fold more DNA damage
(Karlsson et al. 2006).
Mining
Iron-ore deposits occur naturally in the form of iron oxides and other salts (Table 1). Haematite is
commonly found in banded iron formations along with sedimentary deposits of silica (quartz as
chert), and carbonates (Banerjee et al. 2006). Iron-ores, including haematite, frequently occur with
varying proportions of impurities such as alumina, sulphur, phosphorus, titanium, vanadium, zinc,
copper, chromium, nickel, arsenic, lead, tin, and cadmium.
[Table 1]
Significant increases (99% CI) were found for increased rates of lung cancer within the mining
industry in Sweden (HR=1.47). This was further analysed as priori industry groups: metal mines
(HR=1.46); iron/steel mills (HR=1.07 non-significant); iron foundries (HR=1.28); and
blacksmith/welding (HR=1.24 non-significant) (Jung et al. 2018). Despite an overall decrease in lung
cancer among all miners in a Western Australian cohort (SIR=0.91) there was a significant increase
for ever underground vs never underground for lung cancer (IRR=1.81; 95%CI 1.11, 2.93) with
average annual radon exposure for Australian miners lower than the permissible limit (Sodhi-Berry
et al. 2017). There was also a non-significant increase for iron ore only mining vs multiple ore mining
exposure for lung cancer (IRR=1.52; 95%CI 0.98, 2.59), however, these results were not compared to
the general population as confounders such as employment-related variables and smoking could not
be accounted for (Sodhi-Berry et al. 2017). These results are in agreement with an earlier study
which found an increased lung cancer risk at two hematite mines in China (SMR=3.7; 95% CI 2.5, 5.3;
N = 6444) for underground workers. This was reanalysed for those exposed pre and post ventilation
improvement in the mines with a notable decrease in risk with the improvement in ventilation (preventilation (SMR=4.8) and post-ventilation (SMR=2.4)), however, there was no adjusting for smoking
or radon confounders in this study (Chen et al. 1990). There were significant increases over control
for taconite miners exposed to low grade iron ore, with co-exposure to silica and others:
mesothelioma SIR=2.4, lung cancer SIR=1.3, laryngeal cancer SIR=1.4; and stomach cancer SIR=1.4
(Allen et al. 2015). In contrast, other studies have found no increase in rates of lung cancer among
hematite miners (Lawler et al. 1985).
Overall, there is no clear evidence of a causal link between exposure to airborne iron oxide particles
associated with mining and disease. However, there is evidence that exposure to dust from iron ore
mining may be associated with an increased risk of mortality and morbidity. While concomitant risk
factors such as smoking have been shown to be associated with increased risk, both for exposed and
unexposed individuals, there is no evidence that the observed health effects are primarily related to
smoking; the effects appearing synergistic. It is likely that the mechanism of injury involves Fe2O3 in
combination with other agents, in a synergistic or additive relationship.

Geogenic Dust
Geogenic dust is naturally-derived inorganic mineral PM from the desert. There have been few
studies on PM from this source due to limited monitoring in these rural, arid areas. Quantity and
composition of PM from mineral dusts are largely determined by the number and extent of dustblowing events (Engelbrecht et al. 2009). Tavares et al. (2017) found ~19% of ambient PM was iron,
near one of the high iron ore mining regions of Brazil, which was higher than the iron concentration
from corresponding soil samples from the area. This same paper used 57Fe Mössbauer spectroscopy
to determine that the samples of iron found in ambient PM collected at sites >15 km from mining
areas contained large quantities of hematite that can be clearly traced to a mining origin suggesting
that small PM from mining sources is capable of travelling large distances from the source (Tavares
et al. 2017). Aspirated geogenic dusts in mice caused immune suppression with a decrease in alanine
aminotransferase, mean corpuscular volume, plaque forming cells per million spleen cells as well as
small decreases in CD4+ and CD8+ cells (DeWitt et al. 2017). There was also a small increase in
creatinine levels indicating low levels of nephrotoxicity (DeWitt et al. 2017).
Urban Air Pollution
Iron containing ambient PM has been associated with road dust and brake abrasion from motor
vehicles (Hoogh et al. 2013). California 6-cities found a significant correlation for iron in ambient
PM2.5 in association with respiratory hospitalization in <5 year olds following a 3-day lag, however
there was no corresponding association for 5-18 year olds (Ostro et al. 2009). An earlier study found
iron in PM2.5 was significantly correlated with all cause, cardiovascular and >65 years of age mortality
with a three day lag (Ostro et al. 2007). Meta-analysis of previous epidemiological studies found a
large amount of variation between studies (Achilleos et al. 2017). This meta-analysis found a positive
correlation between iron in ambient PM2.5 and all cause and cardiovascular mortality however, these
were not significant due to a large CI.
When ambient PM was analysed for the influence of individual metals, iron was found to have a
positive (non-significant) correlation with an increase in ET-1, E-selectin, ICAM-1 and VCAM-1 (Wu et
al. 2016b). ET-1 is a vasoconstrictor associated with vascular dysregulation in humans. Reduction in
iron in urban PM was associated with an improvement in forced vital capacity lung function
(Boogaard et al. 2013) and iron from road pollution was negatively associated with FEV1 among
truck drivers (Baccarelli et al. 2014). Supporting this in in vitro studies there was a decrease in cell
viability and an increase in ROS and IL-6 production following exposure to motor brakewear particles
(Puisney et al. 2018). Iron in PM2.5 was a significant predictor of FENO50 and JNO levels in children
following exposure to ambient PM which are markers of airway inflammation and bronchial hyperresponsiveness (Pollitt et al. 2016; Rosa et al. 2014).
Printing Toner
Black toner contains carbon black and various iron oxide pigments. Both carbon black and iron oxide
can be bound to polycyclic aromatic hydrocarbons (PAHs) and heavy metals (Gminski et al. 2011).
Chronic inflammation and lung fibrosis have been shown in animal models following long-term
inhalation exposure to toner. In vitro analysis of toners containing <30% iron (by weight) showed no
cytotoxicity and only moderate genotoxicity which the authors attributed to PAHs (Gminski et al.

2011). However, a series of studies investigating the co-exposure of carbon black and iron oxides
have found significant in vitro toxicity (Berg et al. 2010; Guo et al. 2009).
Welding Fumes
Welding fumes contain metals and their oxides as well as additional complex chemical species which
can be volatilized including shielding gases, paints and surface coatings. The various methods of
welding all have their own associated risks and hazards. Mild steel (MS) fumes are usually 80-95%
iron with some manganese (1-15%) where stainless steel (SS) welding fumes commonly contain
nickel (5-10%) and chromium (15-30%) in addition to iron and manganese (Antonini et al. 2004;
Sørensen et al. 2007). Welding fumes have recently been reclassified as carcinogenic to humans
(Group 1) by the International Agency for Research on Cancer (IARC 2017), both for the UV produced
when arc-welding and for the inhalation of welding fumes (Guha et al. 2017).
The earliest investigation of welding fumes was a 1936 paper describing the chest x-rays of 16
welders which found that 9 of the 16 patients had clear nodules present to varying degrees but no
serious physical effects in any of the patients. This was subsequently defined as pulmonary siderosis,
a benign condition produced by inhalation of high concentrations of iron (Doig and McLaughlin
1936). Despite the assumption that siderosis has no associated adverse health effects there have
been numerous cases reported of welders developing nodular interstitial fibrosis (Funahashi et al.
1988; Khalid et al. 2009; McCormick et al. 2008). Andujar et al. (2014) found an increased metal
loading in fibrous regions of the lung in welders with siderophages, ferriginous bodies, fibrotic
lesions and severity of fibrosis all significantly higher in welders compared to controls.
Exposure of a mouse to an occupationally relevant dose for man showed that inhalation of SS
welding fumes (in situ generated) following chemical initiator 3-methylcholanthrene (MCA)
produced a significant increase in the number of tumours per lung (p<0.0001) with a significant
increase in lymphoid infiltrates, presence of foreign material, hyperplasia, adenoma and total lesions
supporting the association between lung cancer and welding (Falcone et al. 2017; Falcone et al.
2018b). There was also a significant increase in tumour multiplicity in A/J strain mice at 78 weeks
following aspiration of SS welding fumes (Zeidler-Erdely et al. 2011). MS fumes also significantly
promoted lung tumour multiplicity in MCA initiated A/J mice despite a lack of chronic inflammation
and no known carcinogenic metals (Falcone et al. 2018b). Additionally, when analysing individual
components of welding fumes Fe2O3 was the greatest contributor to lung inflammation (as a metal
component by weight) (Falcone et al. 2018a). The authors suggest iron may have been responsible
via formation of ROS (Falcone et al. 2018b).
Mannetje et al. (2012) found in a large Europe and UK based study that adjusting for smoking and
asbestos did not attenuate the odds ratio for lung cancer in relation to occupational exposure to
welding fumes. An adjusted odds ratio of 1.19 was found for individuals who had been exposed to
welding fumes and an OR of 1.37 for those whose occupation was welder/flame cutter with a clear
relationship between years of exposure and risk. This correlates with earlier work. Steenland (2002)
found an SMR of 1.46 for welders compared to the general population and three separate metaanalyses have found an increased risk ratio for the association between welding and lung cancer
(RR=1.94 (Sjogren et al. 1994), RR=1.38 (Moulin 1997), RR=1.28 (Ambroise et al. 2006)). Two of these
papers examined both MS and SS and found no significant increase for SS over MS.

Strong radical generation was observed following exposure to both SS and MS fumes with
deferoxamine (chelating agent) and catalase both decreasing observed ROS (Leonard et al. 2010).
Older samples, however, produced significantly less ROS suggesting that studies which collect fumes
on filters and extract may be less informative than those which produce fumes in situ (Falcone et al.
2017; Leonard et al. 2010). Blood leukocytes and neutrophils were both significantly increased in
humans following MS and SS welding though these were short lived, returning to base-line by 22
hours after exposure (Kauppi et al. 2015). There was a significant association between increased
ferritin levels and exposure to iron in welding fumes above 1mg/m3 with increased 8-OH-dG and 8OGG, which are markers of oxidation, in welder’s urine samples (Pesch et al. 2015) and a significant
increase in very high serum ferritin levels for iron-based welders not wearing a respirator compared
to those with a respirator (Casjens et al. 2014). In addition to respirator use there is also some
evidence that use of high voltage welding produces fewer biological indicators of oxidative stress
than regular voltage welding (Sriram et al. 2015).
Challenges of Research to Date
Variations in the synthetic procedure used to generate iron-containing particles can lead to differing
surface profiles which can significantly alter potential toxicity due to variation in the rate of
aggregation and changes in cell surface recognition. Additionally, there appears to be a significant
variation in the toxicity of freshly produced particles compared to those collected on filters and reextracted (Falcone et al. 2017; Leonard et al. 2010). This process changes the surface chemistry and
therefore reactivity as well as the biosolubility of these particles. Often particles prepared via
chemical precipitation in a laboratory are used in in vitro and in vivo studies to replicate the effect of
particular components of ambient PM, often from combustion sources. It is reasonable to assume
that the reactivity and therefore toxicity of these particles would be significantly different. In line
with this, few studies consider the changes to the PM while in the aerosol or the potential
synergistic effects that can occur when exposed to fresh natural PM compared to aged PM collected
on filters or synthesized PM.
Length of exposure in studies is also important with the separation of short term and long term
health effects necessary. There have been very few studies looking at long term exposure,
particularly in in vivo models (Valavanidis et al. 2008). Wu et al. (2016a) found that associations
based on exposure metrics of 2-7 day moving averages when considering PM exposure were
stronger than those based on single day metrics, suggesting cumulative exposure might better
capture air pollution effects than single day exposures. As was the case of for the tobacco industry,
the mining and steel industries appear to have significant input into the funding of research into the
toxicity of iron oxide, leading to a potential unconscious bias in the presentation of findings. All
researchers should be aware of this potential bias when reviewing published work.
In industry-based epidemiological studies, controls are often taken from other parts of the same
company (e.g. surface-workers). These workers have a reasonable probability of still being exposed
to dusts and gases from the mines, albeit at lower concentration, or may have previously worked
underground. Using a population-based control cohort of individuals who have not been exposed
through employment corrects for this (Hedlund et al. 2006). Additionally, when evaluating
epidemiological studies you need to consider the ‘healthy-worker survivor’ effect, where individuals
who are susceptible to adverse health following inhalation of PM have an increased probability of

leaving the industry which results in a work force that may not be representative of the general
population, thus the statistics are likely an underrepresentation of results (Sodhi-Berry et al. 2017).
Aerosol dosimetry studies, which rely heavily on a standardized model of a young healthy male with
even distribution of inhaled particles throughout the lung may not be representative of real life
particle deposition, particularly in individuals with reduced lung health. Deposition hot-spots can
lead to poor predictions of dose in some regions of the lung, particularly the trachea-bronchial
airways, with suggestions that local doses might be out by a factor of several hundred in some
regions (ECETOC 2013; Phalen et al. 2010). Instillation, which is the method used in the majority of in
vivo studies involving iron-containing PM, is not a good model for inhalation toxicology (Brown et al.
2005). Additionally, a large proportion of available toxicity data for all PM, including iron, is
performed on fixed 2D cell cultures which may not provide an adequate representation of toxicity as
they do not have the cell-cell and cell-matrix interactions of an in vivo system (Lee et al. 2009).
Lung overload is a condition where the clearance mechanisms of the lung are unable to cope with
the load of PM. This condition induces an impairment in alveolar macrophage (AM) mediated
pulmonary particle clearance and loss of AM motility (ECETOC 2013). Rat models are particularly
sensitive to lung overload with rats chronically exposed to high concentrations of insoluble particles
experiencing a reduction in pulmonary clearance; this has been shown to lead to pulmonary fibrosis
and benign and malignant tumours (Brown et al. 2008; Olin 2000; Pauluhn and Wiemann 2011).
Hamsters and mice have shown cases of overload where clearance is overwhelmed but the
mechanisms do not appear to be the same as in rats (Olin 2000). Humans, however, are significantly
less sensitive to lung overload with epidemiological studies unable to find a definitive link between
exposure to poorly soluble particles of low toxicity and an increased risk of developing lung cancer
(ECETOC 2013). This is likely to be caused by differences in particle retention and clearance in these
species.
Differences in the anatomy of rats and humans may affect their long-term particle retention and
therefore their chronic toxicity effects (Pauluhn and Wiemann 2011). In addition to complications
involving overload, there are significant differences in clearance rates between rats and humans. The
rat clears >80% of particles from the TB region in ~2 hours; where the same level of clearance in the
human lung takes >16 hours (Brown et al. 2005). As rats clear PM significantly faster than humans,
to simulate a human model, rats would need to be exposed to significantly higher concentrations
and these concentrations are likely to induce overload conditions (Brown et al. 2008). As such, rats
are not a good model for human inhalation toxicology. For acute exposures rats appear to be less
susceptible to inflammatory responses than humans. However, for chronic exposures to high levels
of PM, overload of AM clearance occurs in rats making them more susceptible to adverse pulmonary
effects (Brown et al. 2005, 2008).
A decision was made at a workshop meeting in 2000 that despite the complications relating to
overload, the rat was still the most useful in vivo model available as it is appropriate to select the
most sensitive species when determining potential human risk (Olin 2000). The problem with this is
that anytime high levels of inflammation or tumorigenesis are detected in a rat model following
inhalation or instillation of PM, the overload condition is blamed for the toxicity observed and the
results are ignored. The rat is, therefore, not a useful model for human inhalation toxicology as the

rat under overload conditions, rather than acting as a sensitive model, has become a scapegoat of
toxicological outcomes.
Conclusions and Future Directions
Epidemiological studies across a range of workplaces with high levels of iron oxide exposure have
shown correlation to a range of disease states including cancer, cardiovascular disease and a range
of respiratory diseases. These results have not been well replicated in in vitro and in vivo models.
Following inhalation of iron oxide containing PM the particles are rapidly taken up into macrophages
and epithelial cells with in vivo studies providing evidence of translocation of iron oxide particles to
numerous organs including the brain. This is particularly relevant for UFPs including commercially
generated NPs. Iron is able to become biosoluble following inhalation which can generate ROS via
the Fenton reaction leading to lipid, protein and DNA oxidation. In line with this there have been
suggestions that anti-oxidants such as omega 3 in fish oil, may lessen the oxidative effects of PM
exposure (Romieu et al. 2008). There is also evidence that decreasing systemic iron concentrations
via phlebotomy can lead to a significant reduction in both primary (all-cause mortality HR=44; 95% CI
0.21, 0.92, p=0.028) and secondary (nonfatal myocardial infarction and stroke HR=0.34; 95% CI 0.19,
0.61 p <0.001) outcomes in patients ≤ 55 years of age with peripheral arterial disease (Zacharski et
al. 2011).
No clear conclusions can be drawn from cytotoxicity studies involving iron oxide particles with a
clear need for the use of more appropriate in vitro cell lines both in terms of a suitable choice based
on the expected target organ as well as cell lines with appropriate levels of lysosomal activity
(Kornberg et al. 2017). Additionally, the source of the particles needs to be considered in both in
vitro and in vivo studies with evidence that freshly produced particles appear to produce higher
toxicity than purchased particles or those collected on filters and re-extracted. In particular, care
should be taken in these studies to attempt to replicate the PM surface chemistry, especially likely
oxidation states of the metals, to develop a more accurate model of toxicity. It is likely that in
addition to the important role of surface chemistry, particle morphology and synergistic effects,
leading to potential redox cycling both in the aerosol and once incorporated into lysosomes, will
have a marked effect on particle toxicity. There is a requirement to employ more appropriate animal
models for in vivo studies, with rats not providing the ideal model due to induction of AM overload.
As well as appropriate routes of exposure with evidence suggesting that instillation is not likely to
produce a similar level of exposure to inhalation.
Exposure limits for iron oxide are outlined in Table 2. Australian and US guidelines place a limit on
iron oxide fume exposure of 5 mg/m3 (measured as iron) (Kornberg et al. 2017; Safe Work Australia
2013). These levels are substantially higher than the PM limits and are unlikely to be reached, even
in workplaces with high levels of iron oxide exposure such as welding and foundry work. Moving
forward there needs to be a reassessment of iron exposure, particularly in environments where high
iron concentrations are likely with the consideration of exposure limits for iron-containing UFPs
separately from PM2.5.
[Table 2]

Overall the data on the toxicity of iron oxide PM by inhalation is inconclusive, however, the studies
summarized in this article clearly suggest that iron may be involved in a ROS pathway leading to toxic
effects following inhalation and is potentially not the innocuous, poorly soluble particle it has
previously been characterized as. Our recommendations include an expansion of epidemiological, in
vivo and in vitro studies, integrating the concepts outlined above, such as method of particle
preparation, cell line type, and animal model, to solidify our understanding of the complex biological
interactions of these particles.
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Tables
Table 1: Chemical structure, properties and sources of iron oxides (Banerjee et al. 2006; Park et al.
2014a; Teja and Koh 2009).
Chemical
Formula

Name

Oxidation
State

Properties

Sources/Uses

α-Fe2O3

Hematite,
ferric oxide

Fe(III)

Highly stable;
rhombohedral
corundum; weakly
ferromagnetic or
antiferromagnetic
(<260 K)

Most common form in mineral ore.
Synthesized via precipitation in the
liquid phase. Uses: major source of
iron for steel manufacturing;
pigments; jewellery, radiation
shielding.

γ-Fe2O3

Maghemite

Fe(III)

Isometric, cubic or
tetrahedral defect
spinel; ferrimagnetic

Naturally occurs via weathering of
magnetite, synthesized. Uses:
magnetic tape (audio/video/data
etc), biomedicine.

Fe3O4

Magnetite,
ferrousferric oxide

Fe(II,III)

Cubic inverse spinel;
ferrimagnetic
(strongest of all
transition metal
oxides)

Naturally found in igneous,
metamorphic and sedimentary
rock. Most commonly mined iron
ore. Uses in magnetic applications,
toner, pigments, steel
manufacturing, synthetic catalysts,
water purification, ferrofluids.

FeO

Wüstite

Fe(II)

Fe deficient (~0.85:1)
Isometric, cubic;
antiferromagnetic

Rare form of iron oxide produced in
highly reducing environments.

Table 2: United States workplace exposure limits for the inhalable fraction of iron oxide. OSHA –
Occupational Safety and Health Administration; NIOSH – National Institute for Occupational Safety
and Health; ACHIH – American Conference of Governmental Industrial Hygienists (Banerjee et al.
2006; EPA 1984; Kornberg et al. 2017).
OSHA

The legal airborne permissible limit (PEL) is 10 mg/m3 (measured as iron)
averaged over an 8 hour work shift

NIOSH

The recommended airborne exposure limit is 5 mg/m3 (measured as iron)
averaged over a 10 hour work shift

ACGIH

The recommended airborne exposure limit is 5 mg/m3 (measured as iron)
averaged over an 8 hour work shift

Figure legends
Figure 1: Airborne particles by size including thoracic coarse particles (PM10-2.5), fine particles
(PM2.5), ultrafine (PM0.1) and various components.
Figure 2: Flowchart describing the systematic review selection process to identify articles
describing in vivo, in vitro, or epidemiological studies involving iron oxide or iron oxide containing
PM via inhalation or instillation published in the past 10 years.
Figure 3: Estimated deposition of particles inhaled into the human body. Adapted from Chow and
Watson (1998).
Figure 4: Fate and known or suspected effects caused by iron oxide particles following inhalation
(Brook et al. 2010; Kell 2010; Kornberg et al. 2017; Kunzmann et al. 2011; Niemann et al. 2017;
Stone et al. 2017; Zhu et al. 2009).
Figure 5: Equations describing the Fenton reaction leading to the generation of the hydroxyl
radical and subsequent oxidation of cellular biomolecules mediated by iron. Adapted from Funke
et al. (2013).
Figure 6: Comparison of workplace iron exposure and COPD mortality rates a) location of UK steel
processing plants in 1986, image adapted from British Steel archive, Tata Steel and UK Steel data
(PA Media 2018) b) COPD mortality rates 2008-2012, relative risk range 0.40-3.34 lightest - darkest
(British Lung Foundation 2018) c) location of UK iron mines throughout history provided with
permission by Gazetteer of British Collieries (not all of these mines would have been active during
the lifetime of the individuals referenced in Figure 5b) (Gill 2019).
Figure 7: SEM images demonstrating morphologies of iron PM from different sources. a) fly ash
particles b) mineral dust. Replicated, with permission, from Ault et al. (2012).
Figure 8: SEM images demonstrating the typical morphological aspect of iron PM in subway
samples with flaky and splintery morphologies. Replicated, with permission, from Moreno et al.
(2015).
Figure 9: TEM images showing the gradual oxidation of spherical Fe3O4 NPs (0 min) to form needlelike γ-Fe2O3 particles (60 min). Replicated, with permission, from Park et al. (2015).

